Award
National Cancer Institute 5R01CA275762-04
Novel Biomarkers Predicting Blood Clots in Ovarian Cancer
Recipient
University of TX MD Anderson Cancer Center
Award Amount
$441,654.00
Ceiling
$441,654.00
Awarded
July 14, 2026
Identifier
5R01CA275762-04
The award funds research at the University of Texas MD Anderson Cancer Center to identify biomarkers predicting blood clots in ovarian cancer patients, focusing on mitochondria and podoplanin to improve VTE risk prediction and develop targeted therapies.
Description
This project aims to identify tumor-specific prothrombotic factors in ovarian cancer, focusing on mitochondria and podoplanin, to improve risk prediction and develop targeted therapies for venous thromboembolism (VTE). The study will use tumor specimens, blood samples, and clinical data to investigate novel predictive biomarkers for VTE in ovarian cancer patients receiving chemotherapy.